This video covers a breakthrough study from Switzerland and the Netherlands showing how AI—particularly reinforcement learning—can personalize insulin therapy for people with diabetes. These systems adapt to lifestyle factors, improving glucose control and reducing hypoglycemia. However, barriers like high costs and limited real-world deployment still keep this innovation from reaching patients. The study emphasizes the need for accessibility, transparency, and regulatory support to bring smarter diabetes care to life.